\-\ Texto\\:\\ \ \(0\)\
\-\ noncontributory\ \(52\)\
\-\ chest\\ radiograph\\-pa\\ image\\ from\\ a\\ two\\ view\\ study\\ \\(lateral\\ not\\ shown\\)\\ shows\\ an\\ irregular\\ apical\\ pleural\\ thickening\\ and\\ a\\ heterogeneous\\ and\\ predominantly\\ lucent\\ process\\ at\\ the\\ right\\ apex\\ with\\ 2nd\\ and\\ 3rd\\ rib\\ posterior\\ rib\\ destruction\\.\ \(0\)\
\-\ contrast\\-enhanced\\ ct\\ chest\\ showed\\ a\\ lobular\\ hypodense\\ and\\ minimally\\ enhancing\\ lesion\\ arising\\ from\\ the\\ region\\ of\\ the\\ posterior\\ right\\ lung\\ apex\\ with\\ extension\\ into\\ the\\ adjacent\\ posterior\\ chest\\ wall\\ with\\ extension\\ to\\ involve\\ several\\ levels\\ of\\ c\\-spine\\ neuroforamina\\ and\\ likely\\ involves\\ the\\ brachial\\ plexus\\ and\\ intercostals\\ nerves\\ at\\ that\\ level\\.\ \(0\)\
\-\ pancoast\\ tumor\\ \\(poorly\\ differentiated\\ adenocarcinoma\\)\ \(0\)\
\-\ mesothelioma\ \(67\)\
\-\ lymphoma\ \(373\)\
\-\ plasmacytoma\ \(10\)\
\-\ metastatic\\ malignancies\\ \\(thyroid\\,\\ larynx\\)\ \(0\)\
\-\ lymphomatoid\\ granulomatosis\ \(0\)\
\-\ cervical\\ rib\\ syndrome\ \(0\)\
\-\ tuberculosis\ \(73\)\
\-\ fungal\\ infections\ \(5\)\
\-\ 38\\-year\\-old\\ longstanding\\ female\\ smoker\\ presented\\ with\\ right\\ upper\\ extremity\\ radicular\\ symptoms\\.\ \(1\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ rib\\:\\ 0\\.10013024160226158\ \(0\)\
\-\ radiograph\\-pa\\:\\ 0\\.06887123768723827\ \(0\)\
\-\ apex\\:\\ 0\\.06869809087765469\ \(0\)\
\-\ neuroforamina\\:\\ 0\\.06028832918201866\ \(0\)\
\-\ intercostals\\:\\ 0\\.06028832918201866\ \(0\)\
\-\ 38\\-year\\-old\\:\\ 0\\.06028832918201866\ \(0\)\
\-\ pancoast\\:\\ 0\\.05804081299098912\ \(0\)\
\-\ lymphomatoid\\:\\ 0\\.05804081299098912\ \(0\)\
\-\ larynx\\:\\ 0\\.05366881464774363\ \(0\)\
\-\ chest\\:\\ 0\\.047923335938848094\ \(0\)\
\-\ extension\\:\\ 0\\.047661364393463336\ \(0\)\
\-\ posterior\\:\\ 0\\.04616340348521364\ \(0\)\
\-\ plasmacytoma\\:\\ 0\\.04546707930009771\ \(0\)\
\-\ longstanding\\:\\ 0\\.044375189125291786\ \(0\)\
\-\ radicular\\:\\ 0\\.042838389951494485\ \(0\)\
\-\ brachial\\:\\ 0\\.042564239015468935\ \(0\)\
\-\ malignancies\\:\\ 0\\.042564239015468935\ \(0\)\
\-\ mesothelioma\\:\\ 0\\.0417951759466154\ \(0\)\
\-\ granulomatosis\\:\\ 0\\.0417951759466154\ \(0\)\
\-\ c\\-spine\\:\\ 0\\.04087499598054991\ \(0\)\
\-\ smoker\\:\\ 0\\.03967069379439945\ \(0\)\
\-\ apical\\:\\ 0\\.038466391608248995\ \(0\)\
\-\ lobular\\:\\ 0\\.03770729982345487\ \(0\)\
\-\ contrast\\-enhanced\\:\\ 0\\.03742317760336991\ \(0\)\
\-\ lucent\\:\\ 0\\.03567986860872765\ \(0\)\
\-\ differentiated\\:\\ 0\\.03567986860872765\ \(0\)\
\-\ hypodense\\:\\ 0\\.03556905114785299\ \(0\)\
\-\ minimally\\:\\ 0\\.03473492633983966\ \(0\)\
\-\ nerves\\:\\ 0\\.03389204382412728\ \(0\)\
\-\ 2nd\\:\\ 0\\.03329407447160904\ \(0\)\
\-\ 3rd\\:\\ 0\\.03305117926012442\ \(0\)\
\-\ destruction\\:\\ 0\\.032971863858061785\ \(0\)\
\-\ poorly\\:\\ 0\\.032586933787696296\ \(0\)\
\-\ plexus\\:\\ 0\\.032438119764487745\ \(0\)\
\-\ fungal\\:\\ 0\\.03236476241800462\ \(0\)\
\-\ noncontributory\\:\\ 0\\.03200796525524534\ \(0\)\
\-\ tuberculosis\\:\\ 0\\.031801455434400376\ \(0\)\
\-\ infections\\:\\ 0\\.031733814319219796\ \(0\)\
\-\ involve\\:\\ 0\\.031468958446753535\ \(0\)\
\-\ predominantly\\:\\ 0\\.03127604741089125\ \(0\)\
\-\ involves\\:\\ 0\\.031026026074280524\ \(0\)\
\-\ adenocarcinoma\\:\\ 0\\.028840269098150306\ \(0\)\
\-\ arising\\:\\ 0\\.027635966911999852\ \(0\)\
\-\ levels\\:\\ 0\\.027556651509937212\ \(0\)\
\-\ thyroid\\:\\ 0\\.027361815975974303\ \(0\)\
\-\ shown\\:\\ 0\\.026769114798046854\ \(0\)\
\-\ irregular\\:\\ 0\\.02662770822270609\ \(0\)\
\-\ pleural\\:\\ 0\\.025924610927135126\ \(0\)\
\-\ process\\:\\ 0\\.025703636600271206\ \(0\)\
\-\ view\\:\\ 0\\.02504723928735577\ \(0\)\
\-\ heterogeneous\\:\\ 0\\.02454839966246098\ \(0\)\
\-\ extremity\\:\\ 0\\.024415304450331545\ \(0\)\
\-\ cervical\\:\\ 0\\.0242585266139971\ \(0\)\
\-\ thickening\\:\\ 0\\.02262987945072931\ \(0\)\
\-\ study\\:\\ 0\\.02196586997546843\ \(0\)\
\-\ showed\\:\\ 0\\.02188908803065388\ \(0\)\
\-\ several\\:\\ 0\\.021461662779081153\ \(0\)\
\-\ right\\:\\ 0\\.02113199318227539\ \(0\)\
\-\ adjacent\\:\\ 0\\.021108095657298962\ \(0\)\
\-\ enhancing\\:\\ 0\\.02093713697566218\ \(0\)\
\-\ image\\:\\ 0\\.020853040361700007\ \(0\)\
\-\ from\\:\\ 0\\.019788058018034568\ \(0\)\
\-\ lung\\:\\ 0\\.019337180626865205\ \(0\)\
\-\ wall\\:\\ 0\\.019337180626865205\ \(0\)\
\-\ level\\:\\ 0\\.019241320528491656\ \(0\)\
\-\ two\\:\\ 0\\.019119775293875044\ \(0\)\
\-\ syndrome\\:\\ 0\\.019093020130739387\ \(0\)\
\-\ lymphoma\\:\\ 0\\.019079676831167857\ \(0\)\
\-\ region\\:\\ 0\\.01885625958780713\ \(0\)\
\-\ likely\\:\\ 0\\.018830390358872316\ \(0\)\
\-\ shows\\:\\ 0\\.018354482029131865\ \(0\)\
\-\ presented\\:\\ 0\\.018198106523612572\ \(0\)\
\-\ at\\:\\ 0\\.018090049262994266\ \(0\)\
\-\ \\(\\:\\ 0\\.016930352958840482\ \(0\)\
\-\ metastatic\\:\\ 0\\.016805542215750705\ \(0\)\
\-\ \\)\\:\\ 0\\.01672353965890559\ \(0\)\
\-\ symptoms\\:\\ 0\\.016637949038266712\ \(0\)\
\-\ upper\\:\\ 0\\.016110003948193112\ \(0\)\
\-\ into\\:\\ 0\\.01588536224968521\ \(0\)\
\-\ tumor\\:\\ 0\\.015564314856334463\ \(0\)\
\-\ lateral\\:\\ 0\\.0144270941064418\ \(0\)\
\-\ female\\:\\ 0\\.0137246896206862\ \(0\)\
\-\ lesion\\:\\ 0\\.013598087703128552\ \(0\)\
\-\ that\\:\\ 0\\.011531099441865807\ \(0\)\
\-\ not\\:\\ 0\\.00964702087298387\ \(0\)\
\-\ ct\\:\\ 0\\.009338309792125335\ \(0\)\
\-\ a\\:\\ 0\\.009295307855123468\ \(0\)\
\-\ an\\:\\ 0\\.009231756752224452\ \(0\)\
\-\ and\\:\\ 0\\.00843792214369774\ \(0\)\
\-\ the\\:\\ 0\\.005400362683735383\ \(0\)\
\-\ with\\:\\ 0\\.0036563805028090542\ \(0\)\
\-\ to\\:\\ 0\\.00333646959721083\ \(0\)\
\-\ \\,\\:\\ 0\\.0021149223868538077\ \(0\)\
\-\ of\\:\\ 0\\.0018203718874685692\ \(0\)\
\-\ \\.\\:\\ 0\\.0008320203772815534\ \(0\)\
